Vaccines, blood, antisera, toxins and cultures in   Sri Lanka

Exports In 2023, Sri Lanka exported $2.7M in Vaccines, blood, antisera, toxins and cultures, making it the 84th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 262nd most exported product in Sri Lanka. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Sri Lanka are: India ($2.29M), Maldives ($336k), Norway ($41.9k), Malaysia ($11k), and Sweden ($10.8k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Sri Lanka between 2022 and 2023 were Maldives ($166k), Norway ($26.5k), and Sweden ($10.8k).

Imports In 2023, Sri Lanka imported $31.3M in Vaccines, blood, antisera, toxins and cultures, becoming the 128th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 106th most imported product in Sri Lanka. Sri Lanka imports Vaccines, blood, antisera, toxins and cultures primarily from: India ($10.9M), Austria ($4.61M), United States ($3.78M), Netherlands ($2.4M), and France ($1.53M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Sri Lanka between 2022 and 2023 were United States ($629k), Iran ($531k), and Austria ($487k).